In a move to safeguard its dominant position in cancer treatments, Merck agreed to license a drug from a Chinese company ...

ShareReflecting the painful paradox of the scarcity of the processed products obtained from some significant natural resources Nigeria is abundantly blessed with, we cannot but mention that of Premium ...

GSK has been ramping up its manufacturing for Benlysta in anticipation of the new approval, including in-house capacity at its Rockville plant in Maryland, US, and through a contract manufacturing ...

Constellation Energy has applied to reopen a nuclear power plant on Three Mile Island in the Susquehanna — not the one shut after a coolant failure in 1979, but its long-running neighbor, closed by ...

Anxiety Disorder Treatment market Research Report Covers, Future Trends, Past, Present Data and Deep Analysis 224 W 35TH ST STE 500, NY, UNITED STATES, November 13 ... Elli Lilly, Bayer AG, GSK plc, ...

A higher incidence of asthma in South Africa is likely linked to high cases of bronchitis, according to the Clean Air Fund.

GSK Plc agreed on a partnership deal worth as much as $650 million with US biotech Vesalius Therapeutics to help advance drug ...

AstraZeneca has become the latest big pharma company to devote new cash to its US manufacturing muscle this year as it ...

The US sets an ambitious target to add 200 GW of new nuclear capacity by 2050, aiming to triple its 2020 levels.

Ascend Advanced Therapies, which has been on an expansion tear since debuting three years ago, inked a deal with EW ...

We hope today is manageable and productive. Best of luck, and keep in touch. … GSK plans to depart the biotechnology industry ...

In return, GSK got joint rights to the drug in the US and exclusive rights elsewhere. At the time, Barron said that combinations of a PD-1 with TIGIT, CD96 and PVRIG inhibitors – the latter ...